Palvella Therapeutics (PVLA) Other Non Operating Income (2016 - 2024)
Historic Other Non Operating Income for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $1.7 million.
- Palvella Therapeutics' Other Non Operating Income rose 29339.62% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $771000.0, marking a year-over-year increase of 828.65%. This contributed to the annual value of $1.1 million for FY2024, which is 5449.44% up from last year.
- Latest data reveals that Palvella Therapeutics reported Other Non Operating Income of $1.7 million as of Q4 2024, which was up 29339.62% from -$568000.0 recorded in Q3 2024.
- In the past 5 years, Palvella Therapeutics' Other Non Operating Income registered a high of $1.7 million during Q4 2024, and its lowest value of -$1.8 million during Q4 2020.
- For the 5-year period, Palvella Therapeutics' Other Non Operating Income averaged around $76700.0, with its median value being $86000.0 (2022).
- As far as peak fluctuations go, Palvella Therapeutics' Other Non Operating Income crashed by 233454.55% in 2020, and later surged by 157333.33% in 2021.
- Palvella Therapeutics' Other Non Operating Income (Quarter) stood at -$1.8 million in 2020, then skyrocketed by 120.62% to $378000.0 in 2021, then crashed by 185.98% to -$325000.0 in 2022, then soared by 230.46% to $424000.0 in 2023, then skyrocketed by 293.4% to $1.7 million in 2024.
- Its last three reported values are $1.7 million in Q4 2024, -$568000.0 for Q3 2024, and -$271000.0 during Q2 2024.